hIL1RL1/hIL4/hIL4R

Nomenclature

C57BL/6Smoc-Il1rl1tm4(hIL1RL1)Il4tm3(hIL4)Il4ratm1(hIL4R)Smoc

Cat. NO.

NM-HU-232112

Strain State

Embryo cryopreservation

Export PDF

Gene Summary

Gene Symbol
IL4

Gene Symbol
IL4Ra

Gene Symbol
Il4

Gene Symbol
Il1rl1

Model Description

The hIL4/hIL4R(NM-HU-2000106) was crossed with hIL1RL1(NM-HU-2000067) to generate hIL1RL1/hIL4/hIL4R mice.

Validation Data

image.png

Fig1. Expression of hIL1RL1 on CD4+ T cells in spleen in hIL1RL1/hIL4/hIL4R tKI mice.

image.png

Fig2. Expression of hIL1RL1 on mast cells in bone marrow in hIL1RL1/hIL4/hIL4R tKI mice.

image.png

Fig3. Detection of soluble form hIL4RA (A) and mIL4RA (B) expression in hIL4RA mice by ELISA. 

Abbr. HO: homozygote; WT: Wild type; ND: Not detected.

image.png

Fig4. Analysis of hIL4R expression in the spleen in hIL4/hIL4R dKI mice by FACS. 

image.png

Fig5. Evaluation of an Anti-huIL4Ra mAb in the OXA-Induced Atopic Dermatitis Model in hIL4/hIL4Ra dKI Mice. 

Both dupilumab and Dexamethasone ameliorate overall atopic dermatitis activity in OXA - challenged ears, but only Dexamethasone worked in back skin. (In cooperation with CrownBio)

image.png

Fig6. Dupilumab significantly mitigates inflammatory cell infiltration in lesioned ear. (In cooperation with CrownBio) 

Note: Inflammatory cell infiltration is indicated by black arrows, 10X images

image.png

Fig7. Low dose dupilumab significantly mitigates inflammatory cell infiltration in lesioned skin.  (In cooperation with CrownBio) 

Note: Inflammatory cell infiltration is indicated by black arrows, 10X images

image.png

Fig8. Dexamethasone and dupilumab treatments are well tolerated. Both significantly reduced IgE levels in serum but not spleen weight. (In cooperation with CrownBio) 

Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.

image.png

Fig9. Repeated OXA-induced Th2 cytokine production (hIL-4 elevation) and dupilumab treatment significantly reduces IL-6 and KC/GRO levels in lesioned ear. (In cooperation with CrownBio) 

Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.

image.png

Fig10. Repeated OXA-induced Th2 cytokine production (hIL-4 elevation) and dupilumab treatment significantly reduces IL-5 and IL-2 levels in lesioned skin. (In cooperation with CrownBio) 

Ordinary one-way ANOVA were applied for analysis compared to Isotype group, *p<0.05, **p<0.01, *** p<0.001.


You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Milestones

Our vision is to provide researchers all over the world with comprehensive, convenient and professional animal model services to facilitate a simplified and highly-efficient approach towards uncovering the mysteries of life.

Learn more